Literature DB >> 11319586

Non-HLA barriers to unrelated donor stem cell transplantation.

C Kollman1, T Weis, G E Switzer, M Halet, D Kitajima, J Hegland, D L Confer.   

Abstract

A prospective survey involving 544 searches of the US National Marrow Donor Program (NMDP) Registry was conducted to identify reasons why many patients who have apparent HLA-matched donors do not proceed to transplant. Coordinators at NMDP transplant centers, patients and referring physicians were surveyed shortly after the initial search, and follow-up surveys were sent to the coordinators as the search was ongoing. The death of the patient, worsening of the patient's medical condition and length of the search process were the most commonly cited barriers to transplantation. Other times a decision was made not to transplant through the NMDP due to the use of a donor from another source, a preference for chemotherapy or immunotherapy, hesitancy on the part of the transplant physician or patient, or because the patient did not require a transplant. Responses differed between U.S. and international cases. An unrelated donor outside the NMDP was the most common reason cited by international coordinators (46%), whereas the death of the patient was the most common reason among US coordinators (13%). The death of the patient was the second most common reason cited by international coordinators at 9%. Financial problems were listed by 41% of US coordinators as a potential barrier at the time of initial search, but only 5% indicated this as an actual barrier on a follow-up survey. Finances were cited as the most important reason 3% of the time overall, and 6% for African Americans and Asian/Pacific Islanders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319586     DOI: 10.1038/sj.bmt.1702845

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.

Authors:  Akiko M Saito; Corey Cutler; David Zahrieh; Robert J Soiffer; Vincent T Ho; Edwin P Alyea; John Koreth; Joseph H Antin; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2008-02       Impact factor: 5.742

2.  Giving blood and enrolling on the stem cell donor registry: ranking of obstacles and motives in Switzerland.

Authors:  Thomas Bart; Thomas Volken; Yvonne Fischer; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2014-07-04       Impact factor: 3.747

Review 3.  Racial disparities in hematopoietic cell transplantation in the United States.

Authors:  N S Majhail; S Nayyar; M E Burton Santibañez; E A Murphy; E M Denzen
Journal:  Bone Marrow Transplant       Date:  2011-11-07       Impact factor: 5.483

4.  Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.

Authors:  Amy E DeZern; Marianna L Zahurak; Heather J Symons; Kenneth R Cooke; Gary L Rosner; Douglas E Gladstone; Carol Ann Huff; Lode J Swinnen; Philip Imus; Ivan Borrello; Nina Wagner-Johnston; Richard F Ambinder; Leo Luznik; Javier Bolaños-Meade; Ephraim J Fuchs; Richard J Jones; Robert A Brodsky
Journal:  Blood Adv       Date:  2020-04-28

5.  Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.

Authors:  Amy E DeZern; Marianna Zahurak; Heather Symons; Kenneth Cooke; Richard J Jones; Robert A Brodsky
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-21       Impact factor: 5.742

Review 6.  Access to hematopoietic cell transplantation in the United States.

Authors:  Navneet S Majhail; Nancy A Omondi; Ellen Denzen; Elizabeth A Murphy; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-28       Impact factor: 5.742

7.  Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.

Authors:  Edward W Li; Anna Lee; Maryam Vaseghi-Shanjani; Alexander Anagnostopoulos; Gabriele Jagelaviciute; Elena Kum; Tanya Petraszko; Heidi Elmoazzen; David Allan; Warren Fingrut
Journal:  Transfusion       Date:  2020-12-02       Impact factor: 3.157

8.  Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.

Authors:  Colin Flannelly; Bryan E-Xin Tan; Jian Liang Tan; Colin M McHugh; Chandrika Sanapala; Tara Lagu; Jane L Liesveld; Omar Aljitawi; Michael W Becker; Jason H Mendler; Heidi D Klepin; Wendy Stock; Tanya M Wildes; Andrew Artz; Navneet S Majhail; Kah Poh Loh
Journal:  Biol Blood Marrow Transplant       Date:  2020-09-20       Impact factor: 5.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.